Cushing syndrome (CS) is a rare disorder resulting from prolonged exposure to excess glucocorticoids via exogenous and endogenous sources. The typical clinical features of CS are related to hypercortisolism and include accumulation of central fat, moon facies, neuromuscular weakness, osteoporosis or bone fractures, metabolic complications, and mood changes. Traditionally, endogenous CS is classified as adrenocorticotropic hormone (ACTH)-dependent (about 80%) or ACTH- independent (about 20%). Among ACTH-dependent forms, pituitary corticotroph adenoma (Cushing's disease) is most common. Most pituitary tumors are sporadic, resulting from monoclonal expansion of a single mutated cell. Recently recurrent activating somatic driver mutations in the ubiquitin-specific protease 8 gene (USP8) were identified in almost half of corticotroph adenoma. Germline mutations in MEN1 (encoding menin), AIP (encoding aryl-hydrocarbon receptor-interacting protein), PRKAR1A (encoding cAMP-dependent protein kinase type I alpha regulatory subunit) and CDKN1B (encoding cyclin-dependent kinase inhibitor 1B; also known as p27 Kip1) have been identified in familial forms of pituitary adenomas. However, the frequency of familial pituitary adenomas is less than 5% in patients with pituitary adenomas. Among ACTH-independent CS, adrenal adenoma is most common. Rare adrenal causes of CS include primary bilateral macronodular adrenal hyperplasia (BMAH) or primary pigmented nodular adrenocortical disease (PPNAD).

Human Diseases; Endocrine and metabolic disease
BRITE hierarchy

Loxodonta africana (African savanna elephant) [GN:lav]

PMID:26004339

Lacroix A, Feelders RA, Stratakis CA, Nieman LK

Cushing's syndrome.

Lancet 386:913-27 (2015)
DOI:10.1016/S0140-6736(14)61375-1

PMID:27588171

Xiong Q, Ge W

Gene mutations in Cushing's disease.

Biomed Rep 5:277-282 (2016)
DOI:10.3892/br.2016.729

PMID:25877147

Fukuoka H, Takahashi Y

The role of genetic and epigenetic changes in pituitary tumorigenesis.

Neurol Med Chir (Tokyo) 54 Suppl 3:943-57 (2014)
DOI:10.2176/nmc.suppl.2014-3

PMID:18987159

Quereda V, Malumbres M

Cell cycle control of pituitary development and disease.

J Mol Endocrinol 42:75-86 (2009)
DOI:10.1677/JME-08-0146

PMID:27742789

Caimari F, Korbonits M

Novel Genetic Causes of Pituitary Adenomas.

Clin Cancer Res 22:5030-5042 (2016)
DOI:10.1158/1078-0432.CCR-16-0452

PMID:25350067

Lecoq AL, Kamenicky P, Guiochon-Mantel A, Chanson P

Genetic mutations in sporadic pituitary adenomas--what to screen for?

Nat Rev Endocrinol 11:43-54 (2015)
DOI:10.1038/nrendo.2014.181

PMID:27625633

Hannah-Shmouni F, Faucz FR, Stratakis CA

Alterations of Phosphodiesterases in Adrenocortical Tumors.

Front Endocrinol (Lausanne) 7:111 (2016)
DOI:10.3389/fendo.2016.00111

PMID:21423242

Melmed S

Pathogenesis of pituitary tumors.

Nat Rev Endocrinol 7:257-66 (2011)
DOI:10.1038/nrendo.2011.40

PMID:19407507

Daly AF, Tichomirowa MA, Beckers A

Genetic, molecular and clinical features of familial isolated pituitary adenomas.

Horm Res 71 Suppl 2:116-22 (2009)
DOI:10.1159/000192448

PMID:28850717

Albani A, Theodoropoulou M, Reincke M

Genetics of Cushing's disease.

Clin Endocrinol (Oxf) 88:3-12 (2018)
DOI:10.1111/cen.13457

PMID:26045561

Duan K, Hernandez KG, Mete O

Clinicopathological correlates of adrenal Cushing's syndrome.

Postgrad Med J 91:331-42 (2015)
DOI:10.1136/postgradmedj-2014-202612rep

PMID:26264719

Drougat L, Espiard S, Bertherat J

Genetics of primary bilateral macronodular adrenal hyperplasia: a model for early diagnosis of Cushing's syndrome?

Eur J Endocrinol 173:M121-31 (2015)
DOI:10.1530/EJE-15-0532

PMID:17955016

Stratakis CA, Boikos SA

Genetics of adrenal tumors associated with Cushing's syndrome: a new classification for bilateral adrenocortical hyperplasias.

Nat Clin Pract Endocrinol Metab 3:748-57 (2007)
DOI:10.1038/ncpendmet0648

PMID:19906235

Refojo D, Holsboer F

CRH signaling. Molecular specificity for drug targeting in the CNS.

Ann N Y Acad Sci 1179:106-19 (2009)
DOI:10.1111/j.1749-6632.2009.04983.x

PMID:12089357

Kovalovsky D, Refojo D, Liberman AC, Hochbaum D, Pereda MP, Coso OA, Stalla GK, Holsboer F, Arzt E

Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways.

Mol Endocrinol 16:1638-51 (2002)
DOI:10.1210/mend.16.7.0863

PMID:15380809

Lacroix A, Baldacchino V, Bourdeau I, Hamet P, Tremblay J

Cushing's syndrome variants secondary to aberrant hormone receptors.

Trends Endocrinol Metab 15:375-82 (2004)
DOI:10.1016/j.tem.2004.08.007

PMID:25485838

Reincke M, Sbiera S, Hayakawa A, Theodoropoulou M, Osswald A, Beuschlein F, Meitinger T, Mizuno-Yamasaki E, Kawaguchi K, Saeki Y, Tanaka K, Wieland T, Graf E, Saeger W, Ronchi CL, Allolio B, Buchfelder M, Strom TM, Fassnacht M, Komada M

Mutations in the deubiquitinase gene USP8 cause Cushing's disease.

Nat Genet 47:31-8 (2015)
DOI:10.1038/ng.3166

PMID:25930709

Kaiser UB

Cushing's disease: towards precision medicine.

Cell Res 25:649-50 (2015)
DOI:10.1038/cr.2015.53

PMID:28487882

Uzilov AV, Cheesman KC, Fink MY, Newman LC, Pandya C, Lalazar Y, Hefti M, Fowkes M, Deikus G, Lau CY, Moe AS, Kinoshita Y, Kasai Y, Zweig M, Gupta A, Starcevic D, Mahajan M, Schadt EE, Post KD, Donovan MJ, Sebra R, Chen R, Geer EB

Identification of a novel RASD1 somatic mutation in a USP8-mutated corticotroph adenoma.

Cold Spring Harb Mol Case Stud 3:a001602 (2017)
DOI:10.1101/mcs.a001602

PMID:26285834

Huang C, Shi Y, Zhao Y

USP8 mutation in Cushing's disease.

Oncotarget 6:18240-1 (2015)
DOI:10.18632/oncotarget.4856

PMID:26012588

Theodoropoulou M, Reincke M, Fassnacht M, Komada M

Decoding the genetic basis of Cushing's disease: USP8 in the spotlight.

Eur J Endocrinol 173:M73-83 (2015)
DOI:10.1530/EJE-15-0320

PMID:29370219

Yu L, Zhang J, Guo X, Chen X, He Z, He Q

ARMC5 mutations in familial and sporadic primary bilateral macronodular adrenal hyperplasia.

PLoS One 13:e0191602 (2018)
DOI:10.1371/journal.pone.0191602

PMID:19075677

Wu X, Hua X

Menin, histone h3 methyltransferases, and regulation of cell proliferation: current knowledge and perspective.

Curr Mol Med 8:805-15 (2008)
DOI:10.2174/156652408786733702

PMID:20457215

Ozfirat Z, Korbonits M

AIP gene and familial isolated pituitary adenomas.

Mol Cell Endocrinol 326:71-9 (2010)
DOI:10.1016/j.mce.2010.05.001